| |
Non-referral (N=160) |
Referral (N=55) |
Total (N=215) |
p-values |
| Gender (male) |
80 (50%) |
37 (67.3%) |
117 (54.4%) |
0.027 |
| Race |
|
|
|
0.128 |
| White |
13 (8.1%) |
3 (5.5%) |
16 (7.4%) |
|
| Black |
118 (73.8%) |
51 (92.7%) |
169 (78.6%) |
|
| Hispanic |
13 (8.1%) |
1(1.8%) |
14 (6.5%) |
|
| Age |
55(20-89) |
51 (19-68) |
54(19-89) |
0.052 |
| Diagnosis |
|
|
|
<0.001 |
| HL |
32 (20%) |
8 (14.5%) |
40 (18.6%) |
|
| NHL |
82 (51.2%) |
14 (25.5%) |
96 (44.7%) |
|
| MM |
46 (28.8%) |
33 (60%) |
79 (36.7%) |
|
| Disease Status(R/R) |
25 (15.6%) |
20 (36.4%) |
45 (20.9%) |
0.001 |
| Disease Response (CR+PR) |
85 (53.1%) |
29 (52.7%) |
114 (53.0%) |
0.959 |
| CR |
60 (37.5%) |
8 (14.5%) |
68 (31.6%) |
0.002 |
|
